Mark Iltis, DO
Vascular Surgery · Lexington, KYNPI 1952789430
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,298 of the $22,037 with a category attached, or 60.3%. It is spread thinly across 31 manufacturers, the largest accounting for just 19.6%. 2025 is the largest year on record at $7,016, 2.0 times the $3,485 reported in 2022.
Across 230 payments — averaging $95.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$4K
- Silk Road Medical, Inc.$3K
- Stryker$3K
- Boston Scientific$3K
- Biotissue Holdings Inc.$2K
- Inari Medical, Inc.$2K
- plus $5K from 25 others
What the payments were for
- Travel & lodging$8,73940%
- Food & beverage$13,29860%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 11 | $4,320 |
| Silk Road Medical, Inc. | 29 | $3,391 |
| Stryker | 29 | $3,315 |
| Boston Scientific | 26 | $2,746 |
| Biotissue Holdings Inc. | 9 | $1,692 |
| Inari Medical, Inc. | 17 | $1,536 |
| Medtronic | 22 | $1,333 |
| Endologix LLC | 4 | $762 |
| W. L. Gore & Associates, Inc. | 15 | $673 |
| Integra Lifesciences Corporation | 9 | $369 |
| Shockwave Medical, Inc | 3 | $295 |
| Abbott | 3 | $226 |
| Urgo Medical North America, LLC | 12 | $220 |
| Terumo Medical Corporation | 3 | $201 |
| Bolton Medical Inc | 1 | $149 |
| Bard Peripheral Vascular, Inc. | 1 | $144 |
| Cook Medical LLC | 2 | $120 |
| Polynovo North America LLC | 12 | $108 |
| Kerecis Limited | 5 | $93 |
| Imperative Care, Inc | 2 | $59 |
| Baxter Healthcare | 2 | $57 |
| Smith+Nephew | 2 | $45 |
| Pfizer | 2 | $32 |
| Avinger Inc. | 2 | $27 |
| Contego Medical, Inc | 1 | $23 |
| Convatec Inc. | 1 | $19 |
| Sanara Medtech Inc. | 1 | $18 |
| Cardiovascular Systems Inc. | 1 | $17 |
| Acera Surgical, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| Lemaitre Vascular, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$4,071
- ENROUTE Transcarotid Neuroprotection System$2,947
- ENROUTE Transcarotid Stent$2,574
- CLOTTRIEVER BOLD CATHETER$1,544
- AngioJet Ultra 5000A$1,246
- FLOWTRIEVER CATHETER, S$1,217
- CT THROMBECTOMY SYSTEM KIT$1,217
- Alto Abdominal Stent Graft System$722
- ARTIX MT$579
- INTEGRA$413
- ENDURANT IIS$378
- EKOSONIC$369
- FlowTriever$291
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$282
- TurboHawk$281
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$272
- ELLIPSYS VASCULAR ACCESS SYSTEM$186
- ESPRIT$172
- Varithena Administration Pack$150
- TREO ABDOMINAL STENT-GRAFT SYSTEM$149
How this compares
$22,037 in reported general payments places this provider in the 80th percentile of 72 vascular surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 35 | $25,931 |
| EliquisApixaban | 13 | $8,244 |
| ClopidogrelClopidogrel Bisulfate | 58 | $596 |
| Cilostazol | 23 | $207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $32 | $8,24413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 72 vascular surgery providers in Kentucky.
Other vascular surgery in Lexington
- Igor VoskresenskyLexington$99K
- Nick AbediLexington$95K
- Samuel TyagiLexington$70K
- David MinionLexington$25K
- Keith MenesLexington$20K
- Dong Hee LeeLexington$17K
- Ryan KingLexington$12K
- Junior UniversLexington$10K
- Tana RepellaLexington$9K
- Travis HughesLexington$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.